Efficacy and Safety of IGN-ES001 in Chronic Widespread Pain With or Without Fibromyalgia

NCT03058224 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

230

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Widespread Pain
Fibromyalgia

Interventions

DRUG: IGN-ES001
DRUG: Parol 500 mg Tablets (acetaminophen)

Sponsor

IgNova GmbH

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]